Outlook Therapeutics Inc
NASDAQ:OTLK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
M
|
Mitsubishi Heavy Industries Ltd
DUS:MIH
|
JP |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
|
Century Communities Inc
NYSE:CCS
|
US |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
J
|
JCDecaux SE
SWB:DCS
|
FR |
|
Cosmo Energy Holdings Co Ltd
F:2LW
|
JP |
|
Coca Cola HBC AG
LSE:CCH
|
CH |
|
G
|
GoGold Resources Inc
OTC:GLGDF
|
CA |
|
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
|
US |
|
M
|
Micro Focus International PLC
F:M7Q8
|
UK |
|
A
|
Activision Blizzard Inc
LSE:0H8X
|
US |
|
Scandic Hotels Group AB
STO:SHOT
|
SE |
|
Base Inc
OTC:BAINF
|
JP |
|
C
|
Compagnie Financiere Richemont SA
F:RITN
|
CH |
|
U
|
Union Pacific Corp
SWB:UNP
|
US |
|
T
|
Tegna Inc
XMUN:GTT
|
US |
|
P
|
Perusahaan Gas Negara Tbk PT
SWB:PGB1
|
ID |
|
Metro Bank PLC
LSE:MTRO
|
UK |
|
T
|
TriStar Gold Inc
F:7TG
|
US |
|
Novo Nordisk A/S
BMV:NVON
|
DK |
|
A
|
Arcadis NV
SWB:HIJ2
|
NL |
Bankruptcy Probability
Outlook Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Outlook Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
144.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
465B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Outlook Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Outlook Therapeutics Inc has total debt of 11.1m USD. This includes both short-term (0 USD) and long-term (11.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
